嘉应制药：公司股票交易价格连续3个交易日内收盘价格涨幅偏离值累计超过20%

Core Viewpoint - The stock price of Jiaying Pharmaceutical has experienced a cumulative increase of over 20% in the closing prices over three consecutive trading days (November 13, 14, and 17, 2025) [1] Group 1: Stock Performance - The company's stock price has shown significant volatility, with a cumulative increase exceeding 20% over three trading days [1] - The company has confirmed that there are no corrections or supplements needed for previously disclosed information [1] Group 2: Operational Status - The company's operational situation remains normal, with no significant changes in the internal and external business environment [1] - There have been no recent media reports that could have significantly impacted the company's stock price [1] Group 3: Corporate Governance - The company currently has no controlling shareholder or actual controller [1] - There are no undisclosed significant matters that the company is obligated to disclose, nor are there any significant matters in the planning stage [1]